Coastlands Capital LP bought $8,691 of ADIL
owner at ADIAL PHARMACEUTICALS, INC.. 3,233 shares at an average of $2.69, traded Jul 14, 2026, filed Jul 16, 2026.
Score components
- +12Role10% owner
- 0Trade size$9k at market
- -5Relative to holdingsUnder 1% of holdings (0.8%)
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying3 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-26-084300, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 14, 2026 | POpen-market purchase Common Stockindirect: By Coastlands Capital LP | +2,000 | $2.65 | $5,300 | 387,075 | Jul 16, 2026 |
| Jul 16, 2026 | POpen-market purchase Common Stockindirect: By Coastlands Capital LP | +1,233 | $2.75 | $3,391 | 388,308 | Jul 16, 2026 |
Related signals
Other insiders at ADIAL PHARMACEUTICALS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 18Weak | ADILbuy ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP owner | $33k 11,753 shares | +3% | |
| 18Weak | ADILbuy ADIAL PHARMACEUTICALS, INC. | Coastlands Capital LP owner | $65k 25,000 shares | +7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.